Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SOX”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Testing effectiveness (Phase 2)WithdrawnNCT03991104
What this trial is testing

SOX-based CRT for Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Zhejiang Provincial People's Hospital
Testing effectiveness (Phase 2)Ended earlyNCT01403259
What this trial is testing

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 16
Testing effectiveness (Phase 2)UnknownNCT00961077
What this trial is testing

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

Who this might be right for
ElderlyS-1Oxaliplatin+2 more
Soonchunhyang University Hospital 36
Large-scale testing (Phase 3)UnknownNCT03598348
What this trial is testing

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Huazhong University of Science and Technology 288
Large-scale testing (Phase 3)UnknownNCT02008422
What this trial is testing

Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Tang Xushan 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06213519
What this trial is testing

HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Peritoneal MetastasesGastric Cancer
Sichuan University 69
Testing effectiveness (Phase 2)UnknownNCT02870153
What this trial is testing

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
The First People's Hospital of Changzhou 60
Large-scale testing (Phase 3)UnknownNCT02338518
What this trial is testing

Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients

Who this might be right for
Stomach NeoplasmsGastric Cancer
Jinling Hospital, China 297
Testing effectiveness (Phase 2)UnknownNCT04792515
What this trial is testing

Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer

Who this might be right for
Locally Advanced Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University 67
Testing effectiveness (Phase 2)Looking for participantsNCT06766578
What this trial is testing

Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Shandong Provincial Hospital 32
Large-scale testing (Phase 3)Study completedNCT00677443
What this trial is testing

Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Samsung Medical Center 344
Testing effectiveness (Phase 2)Looking for participantsNCT07699939
What this trial is testing

Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) Adenocarcinoma
National Cancer Center, Japan 136
Testing effectiveness (Phase 2)UnknownNCT05122091
What this trial is testing

Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal CancerFruquintinib+1 more
Guangxi Medical University 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06939452
What this trial is testing

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

Who this might be right for
Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Yongxu Jia 37
Testing effectiveness (Phase 2)Looking for participantsNCT05170503
What this trial is testing

Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma

Who this might be right for
Esophagogastric Junction Adenocarcinoma
Sun Yat-sen University 37
Testing effectiveness (Phase 2)UnknownNCT05346874
What this trial is testing

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Shanghai Zhongshan Hospital 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06764251
What this trial is testing

Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658872
What this trial is testing

Perioperative Fruquintinib Combined With Sintilimab and SOX for Locally Advanced Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaEsophagogastric Junction Adenocarcinoma
Sichuan University 120
Testing effectiveness (Phase 2)UnknownNCT06036745
What this trial is testing

Exploratory Single-arm, Single-center Adjuvant Treatment of Stage IIIB-IIIC Gastric Cancer With Combination of Palizumab and SOX Regimen

Who this might be right for
Gastric Cancer Stage IIIB-IIIC
Shanghai Minimally Invasive Surgery Center 20
Not applicableStudy completedNCT01344304
What this trial is testing

Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial

Who this might be right for
Colorectal Cancer
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 413
Next Page